Trendingnow
Health

By Jared DiamondSeptember 1, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026
Latest stories from Fortune
More HealthPage 4 of 100

By Dee-Ann Durbin and The Associated PressJuly 30, 2026

By The Associated PressJuly 30, 2026

By Mike Stobbe and The Associated PressJuly 30, 2026

By The Associated PressJuly 29, 2026

By Lauran Neergaard, Ali Swenson and The Associated PressJuly 29, 2026

By Olga R. Rodriguez and The Associated PressJuly 29, 2026

By Lauran Neergaard, Ali Swenson and The Associated PressJuly 29, 2026

By Lily Mae LazarusJuly 29, 2026

By Orla NixonJuly 29, 2026

By Joshua HongJuly 29, 2026

By Orianna Rosa RoyleJuly 29, 2026

By Nick LichtenbergJuly 28, 2026

By Devi Shastri and The Associated PressJuly 28, 2026

By Glenn Gamboa and The Associated PressJuly 28, 2026

By Sydney LakeJuly 28, 2026

By The Conversation, Allison Poulos and Jennifer VanosJuly 27, 2026

By The Conversation and Jennifer G. AndrewsJuly 27, 2026

By Oliver BalchJuly 27, 2026

By Sydney LakeJuly 25, 2026

By Roderick WongJuly 25, 2026

By Alyson ShontellJuly 25, 2026

By The Associated Press and Matthew PerroneJuly 24, 2026

By Holly Ramer, ROBERT F. BUKATY and The Associated PressJuly 24, 2026
























